RT Journal Article
SR Electronic
T1 The Modest Impact of Weather and Air Pollution on COVID-19 Transmission
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.05.20092627
DO 10.1101/2020.05.05.20092627
A1 Xu, Ran
A1 Rahmandad, Hazhir
A1 Gupta, Marichi
A1 DiGennaro, Catherine
A1 Ghaffarzadegan, Navid
A1 Amini, Heresh
A1 Jalali, Mohammad S.
YR 2020
UL http://medrxiv.org/content/early/2020/05/24/2020.05.05.20092627.abstract
AB Understanding how environmental factors impact COVID-19 transmission informs global containment efforts. We studied the relative risk of COVID-19 due to weather and ambient air pollution. We estimated the daily reproduction number at 3,739 global locations, controlling for the delay between infection and detection, associating those with local weather conditions and ambient air pollution. Controlling for location-specific fixed effects and local policies, we found a negative relationship between the estimated reproduction number and temperatures above 25°C, a U-shaped relationship with outdoor ultraviolet exposure, and weaker positive associations with air pressure, wind speed, precipitation, diurnal temperature, SO2 and ozone. We projected the relative risk of COVID-19 transmission due to environmental factors in 1,072 global cities. Our projections suggest warmer temperature and moderate outdoor ultraviolet exposure may offer a modest reduction in transmission; however, upcoming changes in weather alone will not be enough to fully contain the transmission of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was used to conduct this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and analysis codes are available on the project website: https://projects.iq.harvard.edu/covid19 https://projects.iq.harvard.edu/covid19